Right now, there are more than 140 vaccines in development around the world, specifically designed to help developing world populations.
The groups and organizations working on developing-world vaccines are of many different types:
- Biotechnology Companies
- Academic/Government Research Groups
- Foundations/Non-Profit Organizations, Including
Product-Development Partnerships (PDPs)
The purpose of the Innovation Bridge is to facilitate new partnerships between and among these vaccine developers and developing country vaccine manufacturers.
It is also possible that researchers in academic/government groups will want to partner with biotechnology companies and/or foundations and PDPs, in order to carry novel vaccine ideas farther forward in the research pipeline.
The Innovation Bridge exists in order to promote and facilitate such partnerships. Click the links above to identify vaccine developers working in five key priority areas for developing-world vaccines identified by the Gates Foundation (HIV/AIDS, malaria, tuberculosis, diarrheal diseases, pneumonia-related diseases).
